Drug intelligence / Profile preview

Hugan Buzhure Granules

Development stage
Unknown
Lead developer
Xinjiang Uygur Pharmaceutical
Administration
Oral
01

Overview

Hugan Buzhure Granules (also known as Hugan Buzure Keli) is a traditional Uyghur medicine (TUM) developed and manufactured by Xinjiang Uygur Pharmaceutical. It is a multi-herb formulation consisting of seven botanical ingredients: celery seed (*Apii Semen*), celery root (*Apii Radix*), chicory seed (*Cichorii Semen*), dodder seed (*Cuscutae Semen*), chicory root (*Cichorii Radix*), fennel root bark (*Foeniculi Cortex*), and fennel fruit (*Foeniculi Fructus*). Officially approved in China, it is traditionally indicated for nourishing the liver and stomach, dispelling gas, relieving pain, promoting bile secretion, and inducing diuresis. It is clinically used to treat liver cold, stomachache, spleen and rib pain, joint pain, rheumatism, and urinary system diseases. Modern pharmacological research indicates that Hugan Buzhure Granules possess hepatoprotective, anti-inflammatory, and anti-fibrotic properties, and can induce autophagy and apoptosis in hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.

Brand names
Xinjiang WeiyaoXipa
Other names
HBGHBRHugan Buzure GranulesHugan Buzure KeliHugan Buzhure Keli护肝布祖热颗粒

Beyond the preview

Go deeper on Hugan Buzhure Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hugan Buzhure Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call